Role of Conjunctival Inflammation in Surgical Outcome After Amniotic Membrane Transplantation With or Without Fibrin Glue for Pterygium
- 1 January 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Cornea
- Vol. 27 (1) , 56-63
Abstract
Purpose: To determine the clinical significance of postoperative conjunctival inflammation noted at the third or fourth week after intraoperative application of mitomycin C and amniotic membrane transplantation for pterygium. Methods: This retrospective study included 27 eyes of 23 patients with primary (n = 12) or recurrent (n = 15) pterygia. All cases were operated by extensive removal of subconjunctival fibrovascular tissue and intraoperative application of 0.04% mitomycin C in the fornix, followed by amniotic membrane transplantation by using either fibrin glue (14 eyes) or sutures (13 eyes). Main outcome measures included development of conjunctival inflammation, pyogenic granuloma, and pterygium recurrence after surgery. Results: For a follow-up of 29.6 ± 17.2 months (range, 6-56 months), 16 (59.3%) eyes without postoperative conjunctival inflammation resulted in favorable outcomes. Conjunctival inflammation around the surgical site was noted in the remaining 11 (40.7%) eyes and was significantly more common in eyes with sutures than those with fibrin glue (61.5% vs. 21.4%, respectively; P = 0.05). Among those with this inflammation, 7 eyes receiving subconjunctival injection of triamcinolone resulted in complete resolution and a good aesthetic outcome. Four eyes without this injection gradually developed conjunctival (n = 1) or corneal (n = 1) recurrence and/or pyogenic granuloma (n = 3). Conclusions: Host conjunctival inflammation is still common after intraoperative application of mitomycin C and amniotic membrane transplantation, especially when sutures are used in pterygium surgery. If left untreated, persistent inflammation may lead to a poor surgical outcome.Keywords
This publication has 30 references indexed in Scilit:
- Efficacy of Subconjunctival 5-Fluorouracil and Triamcinolone Injection in Impending Recurrent PterygiumOphthalmology, 2006
- Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygiaBritish Journal of Ophthalmology, 2005
- Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgeryCurrent Opinion in Ophthalmology, 2004
- Antifibrotics and Wound Healing in Glaucoma SurgerySurvey of Ophthalmology, 2003
- Overexpression of Insulin-like Growth Factor-Binding Protein-2 in Pterygium Body FibroblastsInvestigative Ophthalmology & Visual Science, 2003
- Effect of Pterygium Morphology on Pterygium Recurrence in a Controlled Trial Comparing Conjunctival Autografting With Bare Sclera ExcisionArchives of Ophthalmology (1950), 1997
- Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-β and tumor necrosis factor-α in the pterygiumActa Histochemica, 1996
- Effect of TNF, IL-1, and IL-6 on the proliferation of human Tenon's capsule fibroblasts in tissue culture.British Journal of Ophthalmology, 1995
- Pathogenesis of pterygiumEye, 1989
- Elastodysplasia and Elastodystrophy as the Pathologic Bases of Ocular Pterygia and PingueculaOphthalmology, 1983